107117 <common-name>Reversin 121</common-name> <description>Reversin 121 (C34H47N3O9) is an organic compound that acts as an inhibitor of the ATP-dependent translocase ABCB1. Reversin 121 belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 641.76 g/mol, Reversin 121 is a heavy molecule.</description> <cas>174630-04-7</cas> <pubchem-id>9939298</pubchem-id> <chemical-formula>C34H47N3O9</chemical-formula> <weight nil="true"/> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-05T13:39:55Z</created-at> <updated-at type="dateTime">2026-05-14T19:40:16Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB14072</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)(C)OC(=O)N[C@@H](CC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CCCCNC(=O)OCC1=CC=CC=C1)C(=O)OC(C)(C)C</moldb-smiles> <moldb-formula>C34H47N3O9</moldb-formula> <moldb-inchi>InChI=1S/C34H47N3O9/c1-33(2,3)45-30(40)26(19-13-14-20-35-31(41)44-23-25-17-11-8-12-18-25)36-29(39)27(37-32(42)46-34(4,5)6)21-28(38)43-22-24-15-9-7-10-16-24/h7-12,15-18,26-27H,13-14,19-23H2,1-6H3,(H,35,41)(H,36,39)(H,37,42)/t26-,27-/m0/s1</moldb-inchi> <moldb-inchikey>SVNKEDMVAQBLLN-SVBPBHIXSA-N</moldb-inchikey> <moldb-average-mass type="decimal">641.762</moldb-average-mass> <moldb-mono-mass type="decimal">641.3312301</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.84</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM103010</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id>NS00072588</susdat-id> <iupac>tert-butyl (2S)-2-[(2S)-4-(benzyloxy)-2-{[(tert-butoxy)carbonyl]amino}-4-oxobutanamido]-6-{[(benzyloxy)carbonyl]amino}hexanoate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer">23</paper-count> <sync-id>CED0028809</sync-id> <structure-inchikey>SVNKEDMVAQBLLN-SVBPBHIXSA-N</structure-inchikey> <structure-fingerprint>40000000000000040000800000002400000010080000000004000000010000000000000000000000000000000000000004800000000000000000400000000000000000000000000400008000000000000020001000000100000000009040800000000000010000000000000000000000000000000000080000000000000000000000800040200000800002000000000080000000000100000000000000020000912000000000004000000000082040000000000000000000000000000000000000000000020000000000000000000000000000000000010000000222000000000000000000000000100048000000012400000000000000400000000088000020</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAuAAAALwAAAIABBgBgAAAAAQMGACAAAAAE BgBgAAAAAQMGAGAAAAABAwgAKAAAAAMCBgAoAAAAAwQIACgAAAADAgcAaAAA AAMCAQYgNAAAAAEBBAYAYAAAAAICBgAoAAAAAwQIACgAAAADAggAKAAAAAMC BgBgAAAAAgIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZA aAAAAAMDAQZAaAAAAAMDAQYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGIDQA AAABAQQGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgcAaAAAAAMC AQYAKAAAAAMECAAoAAAAAwIIACgAAAADAgYAYAAAAAICBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGACgA AAADBAgAKAAAAAMCCAAoAAAAAwIGACAAAAAEBgBgAAAAAQMGAGAAAAABAwYA YAAAAAEDCwABAAECAAEDAAEEAAQFIAUGKAIFByAHCAAICQAJCgAKCygCCgwg DA0ADQ4ADg9oDA8QaAwQEWgMERJoDBITaAwIFAAUFSgCFBYgFhcAFxgAGBkA GRoAGhsAGxwAHB0gHR4oAh0fIB8gACAhACEiaAwiI2gMIyRoDCQlaAwlJmgM FycAJygoAicpICkqACorACosACotABMOaAwmIWgMQgIAAAAGDxAREhMOBiIj JCUmIRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:42:15Z</structure-indexed-at> </compound>